ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 177 filers reported holding ARGENX SE in Q4 2020. The put-call ratio across all filers is 1.51 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $75,784,273 | +45.0% | 154,149 | +15.0% | 1.17% | +26.2% |
| Q2 2023 | $52,262,793 | +74.3% | 134,100 | +66.6% | 0.92% | +59.8% |
| Q1 2023 | $29,992,690 | +217.0% | 80,500 | +168.3% | 0.58% | +407.9% |
| Q1 2022 | $9,460,000 | -47.6% | 30,000 | -50.0% | 0.11% | -51.7% |
| Q2 2021 | $18,060,000 | +145.6% | 60,000 | +140.0% | 0.24% | +40.5% |
| Q4 2020 | $7,353,000 | -30.0% | 25,000 | -37.5% | 0.17% | -31.7% |
| Q3 2020 | $10,504,000 | +17.2% | 40,000 | +0.5% | 0.25% | -17.7% |
| Q2 2020 | $8,965,000 | – | 39,800 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 273,343 | $106,529,967 | 17.42% |
| Kynam Capital Management, LP | 184,300 | $71,827,239 | 9.88% |
| Ikarian Capital, LLC | 132,100 | $51,483,333 | 8.20% |
| Avoro Capital Advisors LLC | 1,263,500 | $492,423,855 | 6.68% |
| Artia Global Partners LP | 46,438 | $18,098,282 | 6.24% |
| DCF Advisers, LLC | 25,700 | $10,016,061 | 5.29% |
| Bellevue Group AG | 923,284 | $359,831,473 | 5.13% |
| Eagle Health Investments LP | 64,400 | $25,098,612 | 4.69% |
| Paradigm Biocapital Advisors LP | 150,000 | $58,459,500 | 4.52% |
| Paradigm Biocapital Advisors LP | 142,259 | $55,442,600 | 4.28% |